VANCOUVER, British Columbia, Aug. 10, 2026 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning” or “we”) announced today that it has priced an offering of $300 million principal amount of its 4.231% Senior Unsecured Notes due August 12, 2031 (the “Notes”), which will rank pari passu with existing senior unsecured obligations of Finning. Interest on the Notes is payable semi-annually, commencing on February 12, 2027. Closing of the offering of the Notes is expected to occur on or about August 12, 2026. This offering is being made pursuant to exemptions from the prospectus requirements of applicable securities laws of the provinces of Canada. Purchasers of Notes will be obliged to establish their qualification to invest in accordance with the requirements of the securities laws of the jurisdiction in which they reside....

Diana’s Offer to Acquire All Outstanding Shares of Genco Remains on the Table  Termination of Agreement Has No Impact on Diana’s $1.411 Billion in Committed Financing Nearly Eight Weeks Have Passed Since Diana Delivered Its Revised Offer and the Genco Board Has Delayed Providing a Substantive Response ATHENS, Greece, Aug. 10, 2026 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX) (“Diana” or “the Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels that is the largest shareholder of Genco Shipping & Trading Limited (NYSE: GNK) (“Genco”), and Star Bulk Carriers Corp. (Nasdaq: SBLK) (“Star Bulk”) today announced that following Star Bulk’s request, the parties have mutually terminated their agreement under which Star Bulk would acquire 16 Genco vessels upon completion...

TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the three and six months ended June 30th, 2026, before markets open on Thursday, August 13th, 2026. MediPharm Labs executive management team will also host a conference call and webcast on August 13th, 2026, at 10:00 a.m. (Eastern time) to discuss the Company’s financial results. Conference Call Dial in Details:North America Toll-Free: (888) 330-2454International Toll: +1 (240) 789-2714Conference ID: 4921762Participants are asked to dial in approximately 15 minutes before the start of the call. Webcast:A...

ROMEOVILLE, Ill., Aug. 10, 2026 (GLOBE NEWSWIRE) — Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has rescheduled its second quarter 2026 conference call and webcast. The additional time will allow the Company to complete its quarterly financial reporting and review process. The conference call and webcast will occur on Wednesday, August 19, 2026, at 5:00 p.m. ET. Second Quarter 2026 Conference Call DetailsDate/Time: Wednesday, August 19, 2026 – 4:00 p.m. CT, 5:00 p.m. ET Speakers: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Officer Webcast Link: https://edge.media-server.com/mmc/p/ecgoveo8/ Dial-In Link: https://register-conf.media-server.com/register/BIb4a184933a544641a8f41396efd90a13 To...

Company to conduct one-on-one investor meetings and participate in a fireside chat to be webcast live on Wednesday, August 12, 2026 Management to discuss the Company’s commercial strategy, technology platform and progress toward SOLO™ deployment NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum” or the “Company”) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors, today announced that members of its management team will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place August 11-13, 2026, at the InterContinental Boston, 510 Atlantic Avenue, Boston, Massachusetts. Massimo Morichi, Terra Innovatum’s Chief Strategy Officer and SOLO™ Safeguards Director will host a live presentation and Q&A session at 9:30 a.m. ET on Wednesday,...

Leadership changes focus on enhancing strategic execution and future growth SPOKANE, Wash., Aug. 10, 2026 (GLOBE NEWSWIRE) — Avista (NYSE: AVA) today announced changes to its leadership team, effective Oct. 1, 2026, as part of a planned succession strategy designed to enhance the company’s strategic execution, support future growth and strengthen leadership continuity. Alicia Gibbs, currently Director of Innovation and Strategy, has been appointed Vice President, Growth, Innovation and Strategy. Patrick Ehrbar, currently Director of Regulatory Affairs, has been appointed Vice President, Regulatory Affairs.In her new role, Gibbs will lead efforts focused on growth, innovation and long-range strategic planning. Gibbs joined Avista in 2009 and has held leadership roles across strategy, natural gas operations, electric operations,...

Vancouver, BC, Aug. 10, 2026 (GLOBE NEWSWIRE) — FOBI AI Inc. (FOBI:TSXV) (Pink:FOBIF) (“Fobi” or the “Company”), a company that harnesses AI and data intelligence to enable digital transformation, is pleased to announce that the TSX Venture Exchange (the “TSXV”) has accepted the reinstatement to trading in respect of the Company’s common shares (“Shares”) on the TSXV under the symbol “FOBI”. Trading in respect of the Company’s Shares is expected to recommence shortly following issuance of a TSXV bulletin in connection therewith. The board of directors and the audit committee of the Company currently comprises of three (3) members, being, Rob Anson, Chief Executive Officer of the Company, Jeffrey Hyman, the Chief Financial Officer of the Company, and Peter Green, an independent director of the Company. Accordingly, the Company is...